Loading…
Velico Medical is finalizing plans for new production facilities in Europe and the Indo-Pacific to manufacture FrontlineODP consumables, each capable of producing up to 250,000 units annually, to meet growing demand.
BARDA exercised its third option under a contract with Velico Medical, providing an additional $18.9 million for development of spray dried plasma technology, raising total commitment to $46.5 million.